V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20193067 | 20071831 | 1.64 | 83.6 | Curative (C) | 2020-02-19 | 2020-02-19 | Capecitabine + Mitomycin | 02 | N | CAPECITABINE + MITOMYCIN | 101303905 |
| 20193068 | 20071832 | 1.56 | 35.4 | null | 2019-09-19 | 2019-10-03 | CAPECITABINE + MITOMYCIN + RT | 02 | null | CAPECITABINE + MITOMYCIN | 101838561 |
| 20193070 | 20071833 | 1.77 | 70 | Curative (C) | 2017-04-15 | 2017-05-01 | CAPECITABINE + MITOMYCIN + RT | 02 | N | CAPECITABINE + MITOMYCIN | 100299107 |
| 20193072 | 20071834 | 1.76 | 74.4 | null | 2018-02-05 | 2018-02-25 | Capecitabine + Mitomycin | 01 | null | CAPECITABINE + MITOMYCIN | 100156338 |
| 20193074 | 20071835 | 1.75 | 77.25 | null | 2018-04-12 | 2018-05-08 | Irinotecan + Modified De Gramont | 02 | null | FLUOROURACIL + IRINOTECAN | 101843560 |
| 20193075 | 20071836 | 1.74 | 55.4 | Palliative (P) | 2020-01-07 | 2020-01-19 | Irinotecan + Modified De Gramont | 02 | N | FLUOROURACIL + IRINOTECAN | 101616892 |
| 20193078 | 20071837 | 1.66 | 56.4 | Curative (C) | 2016-03-21 | 2016-03-21 | CAPECITABINE + MITOMYCIN + RT | 02 | N | CAPECITABINE + MITOMYCIN | 101362317 |
| 20193079 | 20071838 | 1.77 | 117 | Curative (C) | 2016-08-04 | 2016-08-16 | CAPECITABINE + MITOMYCIN + RT | 02 | Y | CAPECITABINE + MITOMYCIN | 101477267 |
| 20193080 | 20071839 | 1.71 | 72 | Curative (C) | 2016-04-01 | 2016-05-08 | CAPECITABINE + MITOMYCIN + RT | 02 | Y | CAPECITABINE + MITOMYCIN | 100206262 |
| 20193081 | 20071840 | 1.52 | 48 | null | 2016-12-28 | 2017-01-31 | CAPECITABINE + MITOMYCIN + RT | 02 | null | CAPECITABINE + MITOMYCIN | 100033225 |
| 20193082 | 20071841 | 1.75 | 98 | Palliative (P) | 2017-05-10 | 2017-05-22 | Irinotecan + Modified De Gramont | 02 | N | FLUOROURACIL + IRINOTECAN | 101435034 |
| 20193083 | 20071842 | 1.57 | 64 | Curative (C) | 2017-11-15 | 2017-11-29 | Capecitabine + Mitomycin | N | Y | CAPECITABINE + MITOMYCIN | 100322906 |
| 20193086 | 20071843 | 1.65 | 75.5 | Neo-adjuvant (N) | 2016-02-03 | 2016-02-23 | FLUOROURACIL + IRINOTECAN | 02 | N | FLUOROURACIL + IRINOTECAN | 100130381 |
| 20193087 | 20071844 | 1.74 | 85 | Curative (C) | 2018-08-26 | 2018-09-15 | Capecitabine + Mitomycin | 02 | Y | CAPECITABINE + MITOMYCIN | 101779401 |
| 20193088 | 20071845 | 1.78 | 63 | 03 | 2016-06-25 | 2016-07-06 | Irinotecan + Modified De Gramont | 02 | N | FLUOROURACIL + IRINOTECAN | 101775871 |
| 20193091 | 20071846 | 1.5 | 86 | Palliative (P) | 2016-08-20 | 2016-08-20 | Irinotecan + Modified De Gramont | 02 | N | FLUOROURACIL + IRINOTECAN | 101629647 |
| 20193092 | 20071847 | 1.59 | 87.5 | null | 2018-11-14 | 2018-11-23 | IRINOTECAN + MDG | 02 | null | FLUOROURACIL + IRINOTECAN | 101640974 |
| 20193093 | 20071848 | 1.8 | 97.5 | Palliative (P) | 2016-12-24 | 2016-12-26 | Irinotecan + Modified De Gramont | 02 | N | FLUOROURACIL + IRINOTECAN | 101857797 |
| 20193095 | 20071849 | 1.77 | 79.5 | Palliative (P) | 2019-04-28 | 2019-04-28 | Irinotecan + Modified De Gramont | 02 | N | FLUOROURACIL + IRINOTECAN | 101425286 |
| 20193100 | 20071850 | 1.68 | 111.2 | Palliative (P) | 2018-03-04 | 2018-03-23 | FLUOROURACIL + IRINOTECAN | 02 | N | FLUOROURACIL + IRINOTECAN | 100590231 |
| 20193102 | 20071851 | 1.63 | 84.3 | Palliative (P) | 2019-01-21 | 2019-01-23 | IRINOTECAN + MDG | 02 | N | FLUOROURACIL + IRINOTECAN | 101335051 |
| 20193104 | 20071852 | 1.62 | 77.3 | Curative (C) | 2016-05-30 | 2016-06-09 | CAPECITABINE + MITOMYCIN + RT | 02 | Y | CAPECITABINE + MITOMYCIN | 100328406 |
| 20193105 | 20071853 | 1.78 | 97.9 | Palliative (P) | 2017-04-24 | 2017-05-06 | Irinotecan + Modified De Gramont | 02 | N | FLUOROURACIL + IRINOTECAN | 100133604 |
| 20193106 | 20071854 | 1.64 | 98.6 | Curative (C) | 2016-01-23 | 2016-02-20 | CAPECITABINE + MITOMYCIN + RT | 02 | Y | CAPECITABINE + MITOMYCIN | 100223554 |
| 20193108 | 20071855 | 1.67 | 52 | Curative (C) | 2018-08-03 | 2018-08-08 | CAPECITABINE + MITOMYCIN + RT | 02 | Y | CAPECITABINE + MITOMYCIN | 100892743 |
| 20193109 | 20071856 | 1.82 | 59.8 | Curative (C) | 2016-09-12 | 2016-09-16 | CAPECITABINE + MITOMYCIN + RT | null | null | CAPECITABINE + MITOMYCIN | 100567679 |
| 20193112 | 20071857 | 1.76 | 114.3 | 02 | 2018-09-13 | 2018-10-11 | CAPECITABINE + MITOMYCIN + RT | 02 | Y | CAPECITABINE + MITOMYCIN | 101044910 |
| 20193114 | 20071858 | 1.8 | 90.5 | Neo-adjuvant (N) | 2017-06-26 | 2017-07-16 | Capecitabine + Mitomycin | 02 | Y | CAPECITABINE + MITOMYCIN | 101075229 |
| 20193115 | 20071859 | 1.65 | 93.6 | Curative (C) | 2018-01-23 | 2018-02-09 | CAPECITABINE + MITOMYCIN + RT | 02 | Y | CAPECITABINE + MITOMYCIN | 101173668 |
| 20193118 | 20071860 | 1.91 | 52.4 | Curative (C) | 2019-06-10 | 2019-07-01 | CAPECITABINE + MITOMYCIN + RT | 02 | Y | CAPECITABINE + MITOMYCIN | 100328879 |
| 20193121 | 20071861 | 1.64 | 48.8 | Curative (C) | 2019-06-22 | 2019-07-12 | CAPECITABINE + MITOMYCIN + RT | 02 | null | CAPECITABINE + MITOMYCIN | 100612029 |
| 20193122 | 20071862 | 1.66 | 93.6 | null | 2019-05-18 | 2019-05-25 | Capecitabine + Mitomycin | null | null | CAPECITABINE + MITOMYCIN | 101429655 |
| 20193124 | 20071863 | 1.65 | 72 | Palliative (P) | 2017-04-03 | 2017-04-23 | Capecitabine + Mitomycin | 02 | N | FLUOROURACIL + IRINOTECAN | 100069051 |
| 20193126 | 20071864 | 1.89 | 67.5 | Curative (C) | 2017-09-07 | 2017-09-18 | Capecitabine + Mitomycin | 02 | Y | CAPECITABINE + MITOMYCIN | 101615205 |
| 20193130 | 20071865 | 1.6 | 71 | Neo-adjuvant (N) | 2019-09-28 | 2019-09-28 | Irinotecan + Modified De Gramont | 02 | N | FLUOROURACIL + IRINOTECAN | 101424587 |
| 20193132 | 20071866 | 1.75 | 82 | Palliative (P) | 2016-05-16 | 2016-05-22 | Irinotecan + Modified De Gramont | 02 | N | FLUOROURACIL + IRINOTECAN | 101741250 |
| 20193134 | 20071867 | 1.63 | 101 | Curative (C) | 2016-09-07 | 2016-09-08 | Capecitabine + Mitomycin | N | Y | CAPECITABINE + MITOMYCIN | 100875027 |
| 20193137 | 20071868 | 1.86 | 76.5 | Curative (C) | 2018-08-16 | 2018-09-05 | Capecitabine + Mitomycin | 02 | Y | CAPECITABINE + MITOMYCIN | 100026242 |
| 20193139 | 20071869 | 1.6 | 80.5 | Curative (C) | 2017-09-02 | 2017-09-19 | Capecitabine + Mitomycin | N | Y | CAPECITABINE + MITOMYCIN | 101308890 |
| 20193141 | 20071870 | 1.73 | 78 | Palliative (P) | 2016-08-07 | 2016-08-07 | Irinotecan + Modified De Gramont | 02 | N | FLUOROURACIL + IRINOTECAN | 101739134 |
| 20193142 | 20071871 | 1.65 | 72.8 | Palliative (P) | 2017-12-08 | 2017-12-23 | Irinotecan + Modified De Gramont | 02 | N | FLUOROURACIL + IRINOTECAN | 100697722 |
| 20193144 | 20071872 | 1.64 | 95.6 | Palliative (P) | 2016-04-13 | 2016-04-20 | Irinotecan + Modified De Gramont | 02 | N | FLUOROURACIL + IRINOTECAN | 100543410 |
| 20193146 | 20071873 | 1.64 | 100 | Palliative (P) | 2016-05-15 | 2016-06-24 | Irinotecan + Modified De Gramont | 02 | N | FLUOROURACIL + IRINOTECAN | 101701100 |
| 20193147 | 20071874 | 1.76 | 67.8 | Palliative (P) | 2019-10-03 | 2019-10-17 | Irinotecan + Modified De Gramont | 02 | null | FLUOROURACIL + IRINOTECAN | 100461315 |
| 20193148 | 20071875 | 1.62 | 85 | Curative (C) | 2018-11-04 | 2018-11-11 | Capecitabine + Mitomycin | 01 | N | CAPECITABINE + MITOMYCIN | 101519102 |
| 20193149 | 20071876 | 1.76 | 59.85 | 03 | 2017-10-29 | 2017-11-14 | Capecitabine + Mitomycin | 02 | Y | CAPECITABINE + MITOMYCIN | 101101776 |
| 20193151 | 20071877 | 1.56 | 79.3 | Curative (C) | 2017-03-07 | 2017-03-22 | Capecitabine + Mitomycin | 02 | Y | CAPECITABINE + MITOMYCIN | 101427081 |
| 20193152 | 20071878 | 1.56 | 94.2 | null | 2017-10-16 | 2017-10-16 | FLUOROURACIL + IRINOTECAN | 02 | null | FLUOROURACIL + IRINOTECAN | 101500383 |
| 20193154 | 20071879 | 1.6 | 104 | null | 2017-09-16 | 2017-09-18 | FLUOROURACIL + IRINOTECAN | 02 | Y | FLUOROURACIL + IRINOTECAN | 100474347 |
| 20193155 | 20071880 | 1.76 | 61.9 | Palliative (P) | 2017-08-06 | 2017-08-13 | FLUOROURACIL + IRINOTECAN | 02 | N | FLUOROURACIL + IRINOTECAN | 100399372 |